Znanstveni rad - Pregledni rad
Targeting PVR (CD155) and its receptors in anti-tumor therapy

Kučan Brlić, Paola; Lenac Roviš, Tihana; Cinamon, Guy; Tsukerman, Pini; Mandelboim, Ofer; Jonjić, Stipan (2018)
Citirajte ovaj rad

Kučan Brlić, P., Lenac Roviš, T., Cinamon, G., Tsukerman, P., Mandelboim, O. i Jonjić, S. (2018). Targeting PVR (CD155) and its receptors in anti-tumor therapy. Cellular and Molecular Immunology. doi: 10.1038/s41423-018-0168-y

Kučan Brlić, Paola, et al. "Targeting PVR (CD155) and its receptors in anti-tumor therapy." Cellular and Molecular Immunology, 2018. https://doi.org/10.1038/s41423-018-0168-y

Kučan Brlić, Paola, Tihana Lenac Roviš, Guy Cinamon, Pini Tsukerman, Ofer Mandelboim i Stipan Jonjić. "Targeting PVR (CD155) and its receptors in anti-tumor therapy." Cellular and Molecular Immunology (2018). https://doi.org/10.1038/s41423-018-0168-y

Kučan Brlić, P., et al. (2018) 'Targeting PVR (CD155) and its receptors in anti-tumor therapy', Cellular and Molecular Immunology. doi: 10.1038/s41423-018-0168-y

Kučan Brlić P, Lenac Roviš T, Cinamon G, Tsukerman P, Mandelboim O, Jonjić S. Targeting PVR (CD155) and its receptors in anti-tumor therapy. Cellular and Molecular Immunology [Internet]. 01.10.2018. [pristupljeno 18.09.2019.]. doi: 10.1038/s41423-018-0168-y

P. Kučan Brlić, T. Lenac Roviš, G. Cinamon, P. Tsukerman, O. Mandelboim i S. Jonjić, "Targeting PVR (CD155) and its receptors in anti-tumor therapy", Cellular and Molecular Immunology, Listopad 2018. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:504690. [Citirano: 18.09.2019.]